Search

Your search keyword '"Rekhtman, Natasha"' showing total 1,050 results

Search Constraints

Start Over You searched for: Author "Rekhtman, Natasha" Remove constraint Author: "Rekhtman, Natasha"
1,050 results on '"Rekhtman, Natasha"'

Search Results

1. Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

3. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

5. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

6. Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

7. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment

11. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

12. Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies

13. Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers

16. Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

17. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

18. The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

19. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

23. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

26. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

28. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

30. Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases.

34. Special Stains

37. Immunostains: Introduction

38. Immunostains: Solid Tumors

42. Tumor Syndromes

46. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

48. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

50. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Catalog

Books, media, physical & digital resources